장수 항노화 요법 시장 규모, 점유율, 성장 분석, 요법 유형별, 응용 분야별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Longevity Anti-senescence Therapy Market Size, Share, and Growth Analysis, By Type of Therapy, By Application Areas, By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드:1814202
리서치사:SkyQuest
발행일:2025년 09월
페이지 정보:영문 188 Pages
라이선스 & 가격 (부가세 별도)
한글목차
장수 항노화 요법 세계 시장 규모는 2023년에 201억 달러로 평가되었고, 2024년 228억 5,000만 달러에서 2032년에는 638억 3,000만 달러에 이르고, 예측 기간(2025-2032년) CAGR은 13.7%를 보일 전망입니다.
생명공학 및 재생의료의 눈부신 발전과 함께 건강한 노화, 예방의학, 정밀의료에 대한 관심이 높아지면서 헬스케어 및 제약 부문에서 장수 및 노화방지 요법에 대한 막대한 투자가 이루어지고 있습니다. 또한 줄기세포, 유전자 치료, 세포 초기화 등의 기술이 빠르게 발전하면서 전 세계적으로 수요가 증가하고 있는 것도 시장을 견인하고 있습니다. 또한, AI를 활용한 진단, 바이오마커 개발, 정교한 신약개발 플랫폼의 통합은 특히 신경퇴행성, 심장병, 대사성 질환, 종양학 등의 분야에서 다양한 기회를 창출하고 있습니다. 항노화 치료는 세포의 노화를 되돌리거나 지연시키는 다양한 능력을 발휘하여 치료 프로토콜의 효과를 높이고 환자 결과를 개선하는 동시에 비용을 최소화하여 세계 장수 항노화 치료제 시장 확대에 기여하고 있습니다.
목차
서론
조사 목적
조사 범위
정의
조사 방법
정보 조달
2차와 1차 데이터 방법
시장 규모 예측
시장 전제조건과 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학과 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인과 기회
성장 억제요인과 과제
Porter의 Five Forces 분석
주요 시장 인사이트
중요 성공 요인
경쟁 정도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제 지표
밸류체인 분석
가격 분석
장수 항노화 요법 시장 규모 : 치료 유형별&CAGR(2025-2032)
시장 개요
의약품
생물학적 제제
유전자 치료
세포치료
뉴트라슈티컬
장수 항노화 요법 시장 규모 : 용도 분야별&CAGR(2025-2032)
시장 개요
노화에 따른 질환
심혈관 질환
신경 퇴행성 질환
암
인지 기능 저하
건강 수명 연장
재생의료
장수 항노화 요법 시장 규모 : 유통 채널별&CAGR(2025-2032)
시장 개요
시판약(OTC)
처방전
온라인 판매
병원 약국
장수 항노화 요법 시장 규모 : 연령층별&CAGR(2025-2032)
시장 개요
성인(35-50세)
고령자(51세 이상)
장수 항노화 요법 시장 규모 : 성별&CAGR(2025-2032)
시장 개요
남성
여성
장수 항노화 요법 시장 규모 : 배송 방법별&CAGR(2025-2032)
시장 개요
주사제
경구
국소 적용
임플란트
장수 항노화 요법 시장 규모&CAGR(2025-2032)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카공화국
기타 중동 및 아프리카
경쟁 정보
주요 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채택한 전략
최근 시장 동향
기업의 시장 점유율 분석(2024년)
주요 기업 개요
기업 상세
제품 포트폴리오 분석
기업 부문별 점유율 분석
매출 전년대비 비교(2022-2024년)
주요 기업 개요
Altos Labs(USA)
Calico(USA)
Unity Biotechnology(USA)
Life Biosciences(USA)
Insilico Medicine(Hong Kong)
Elevian(USA)
BioAge Labs(USA)
Cambrian BioPharma(USA)
Juvenescence Ltd.(UK)
Retro Biosciences(USA)
Rubedo Life Sciences(USA)
Turn Biotechnologies(USA)
AgeX Therapeutics(USA)
BlueRock Therapeutics(USA)
LyGenesis(USA)
Shift Bioscience(UK)
Halia Therapeutics(USA)
Celularity(USA)
T.A. Sciences(USA)
Rejuvenate Bio(USA)
결론과 제안
LSH
영문 목차
영문목차
Global Longevity Anti-senescence Therapy Market size was valued at USD 20.1 billion in 2023 and is poised to grow from USD 22.85 billion in 2024 to USD 63.83 billion by 2032, growing at a CAGR of 13.7% during the forecast period (2025-2032).
The rising focus on healthy aging, preventive medicine, and precision medicine, alongside significant advancements in biotechnology and regenerative medicine, is catalyzing substantial investment in longevity and anti-senescence therapies within the healthcare and pharmaceutical sectors. The market is further propelled by the swift progress of technologies such as stem cells, gene therapy, and cellular reprogramming, fostering a robust global demand. Additionally, the integration of AI-driven diagnostics, biomarker development, and sophisticated drug discovery platforms is creating diverse opportunities, particularly in fields like neurodegeneration, cardiology, metabolic disorders, and oncology. Anti-senescence therapies exhibit versatile capabilities to reverse or slow cellular aging, enhancing treatment protocol efficacy and improving patient outcomes while also minimizing costs, contributing to the expansion of the global longevity anti-aging therapy market.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Longevity Anti-senescence Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Longevity Anti-senescence Therapy Market Segments Analysis
Global Longevity Anti-senescence Therapy Market is segmented by Type of Therapy, Application Areas, Distribution Channel, Age Group, Gender, Mode of Delivery and region. Based on Type of Therapy, the market is segmented into Pharmaceuticals, Biologics, Gene Therapy, Cellular Therapy and Nutraceuticals. Based on Application Areas, the market is segmented into Age-related Diseases, Healthspan Extension and Regenerative Medicine. Based on Distribution Channel, the market is segmented into Over-the-counter (OTC), Prescription, Online Sales and Hospital Pharmacies. Based on Age Group, the market is segmented into Adults (35-50 years) and Seniors (51 years and above). Based on Gender, the market is segmented into Male and Female. Based on Mode of Delivery, the market is segmented into Injectables, Oral, Topical Applications and Implants. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Longevity Anti-senescence Therapy Market
The global aging population is experiencing unprecedented growth, significantly boosting the demand for anti-senescence therapies aimed at enhancing both lifespan and healthspan. As more individuals reach advanced ages, the necessity for effective medical interventions rises, particularly to manage age-related conditions like cardiovascular diseases, neurodegeneration, and osteoporosis, which were far less prevalent in the past. This demographic shift places immense pressure on governments, healthcare systems, and private institutions to address the growing impact of these comorbidities. Consequently, there is a surge in funding directed towards research in anti-senescence and longevity, marking a dynamic era for therapeutic advancements in this field.
Restraints in the Global Longevity Anti-senescence Therapy Market
The Global Longevity Anti-senescence Therapy market is significantly hindered by the lengthy and expensive process of bringing new therapies to fruition. Developing effective anti-aging treatments often requires substantial investments, commonly amounting to hundreds of millions of dollars, alongside a protracted timeline spanning several years prior to reaching the market. These therapies encounter unique challenges, especially related to the duration of clinical trials and the assessment of long-term efficacy and safety. Furthermore, demonstrating broad efficacy typically necessitates diverse patient populations, complicating the development and regulatory approval pathways. Regulatory agencies demand a robust evidence base for approving therapies targeting the complex process of aging rather than isolated diseases.
Market Trends of the Global Longevity Anti-senescence Therapy Market
The Global Longevity Anti-senescence Therapy market is witnessing a notable trend centered around the integration of artificial intelligence (AI) with precision medicine. This convergence enhances the efficiency of developing anti-senescence therapies by utilizing AI for advanced analysis and predictive modeling, significantly reducing costs and timelines. Tailoring therapies to individual genetic, proteomic, and biomarker profiles enables a more effective approach to combat aging. As the focus on personalized medicine intensifies, therapies are increasingly being designed to target specific genetic pathways associated with senescence, fostering innovation and opening new avenues for age-related health interventions. This trend positions the market for robust growth and diversification.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Longevity Anti-senescence Therapy Market Size by Type of Therapy & CAGR (2025-2032)
Market Overview
Pharmaceuticals
Biologics
Gene Therapy
Cellular Therapy
Nutraceuticals
Global Longevity Anti-senescence Therapy Market Size by Application Areas & CAGR (2025-2032)
Market Overview
Age-related Diseases
Cardiovascular Diseases
Neurodegenerative Disorders
Cancer
Cognitive Decline
Healthspan Extension
Regenerative Medicine
Global Longevity Anti-senescence Therapy Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Over-the-counter (OTC)
Prescription
Online Sales
Hospital Pharmacies
Global Longevity Anti-senescence Therapy Market Size by Age Group & CAGR (2025-2032)
Market Overview
Adults (35-50 years)
Seniors (51 years and above)
Global Longevity Anti-senescence Therapy Market Size by Gender & CAGR (2025-2032)
Market Overview
Male
Female
Global Longevity Anti-senescence Therapy Market Size by Mode of Delivery & CAGR (2025-2032)
Market Overview
Injectables
Oral
Topical Applications
Implants
Global Longevity Anti-senescence Therapy Market Size & CAGR (2025-2032)
North America (Type of Therapy, Application Areas, Distribution Channel, Age Group, Gender, Mode of Delivery)
US
Canada
Europe (Type of Therapy, Application Areas, Distribution Channel, Age Group, Gender, Mode of Delivery)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Type of Therapy, Application Areas, Distribution Channel, Age Group, Gender, Mode of Delivery)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Type of Therapy, Application Areas, Distribution Channel, Age Group, Gender, Mode of Delivery)
Brazil
Rest of Latin America
Middle East & Africa (Type of Therapy, Application Areas, Distribution Channel, Age Group, Gender, Mode of Delivery)
